Abstract
Dr. Marks has misconstrued the point of our article. Although we agree with him that data on the national prevalence of ampicillin-resistant Haemophilus influenzae type b would be valuable, we feel that the significance of the problem is clear from the wide geographic distribution, the potential virulence of the organism, and continuing reports that it may represent up to 10% of strains of H. influenzae type b isolated within particular institutions.1 Discussion of therapy seems quite appropriate in a report detailing the emergence of an organism resistant to standard treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
